Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |